The Synergy between Deep Learning and Organs-on-Chips for High-Throughput Drug Screening: A Review.

Biosensors (Basel)

Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA 02139, USA.

Published: March 2023

Organs-on-chips (OoCs) are miniature microfluidic systems that have arguably become a class of advanced in vitro models. Deep learning, as an emerging topic in machine learning, has the ability to extract a hidden statistical relationship from the input data. Recently, these two areas have become integrated to achieve synergy for accelerating drug screening. This review provides a brief description of the basic concepts of deep learning used in OoCs and exemplifies the successful use cases for different types of OoCs. These microfluidic chips are of potential to be assembled as highly potent human-on-chips with complex physiological or pathological functions. Finally, we discuss the future supply with perspectives and potential challenges in terms of combining OoCs and deep learning for image processing and automation designs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046732PMC
http://dx.doi.org/10.3390/bios13030389DOI Listing

Publication Analysis

Top Keywords

deep learning
16
drug screening
8
screening review
8
learning
5
synergy deep
4
learning organs-on-chips
4
organs-on-chips high-throughput
4
high-throughput drug
4
review organs-on-chips
4
oocs
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!